Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ![]() Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 1995 | Founding Date 1978 | Founding Date 1951 | Founding Date 2010 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations New Delhi, IN HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | |
Employees | Employees 16,2532% increase | Employees 7,605 | Employees 8,5201% increase | Employees 14,858 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income ₹6.7b (FY, 2026) |
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyAlembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company